SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-040007
Filing Date
2020-08-13
Accepted
2020-08-13 16:06:08
Documents
87
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fmtx-10q_20200630.htm 10-Q 3850639
2 EX-31.1 fmtx-ex311_133.htm EX-31.1 15517
3 EX-31.2 fmtx-ex312_132.htm EX-31.2 15638
4 EX-32.1 fmtx-ex321_131.htm EX-32.1 8034
  Complete submission text file 0001564590-20-040007.txt   10516314

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT fmtx-20200630.xml EX-101.INS 1930189
6 XBRL TAXONOMY EXTENSION SCHEMA fmtx-20200630.xsd EX-101.SCH 77204
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fmtx-20200630_cal.xml EX-101.CAL 54037
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fmtx-20200630_def.xml EX-101.DEF 280524
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fmtx-20200630_lab.xml EX-101.LAB 525134
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fmtx-20200630_pre.xml EX-101.PRE 430131
Mailing Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472
Business Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39333 | Film No.: 201099303
SIC: 2836 Biological Products, (No Diagnostic Substances)